High-Dose Radiation as a Dramatic, Immunological Primer in Locally Advanced Melanoma
A 53-year-old white male presented with a right axillary melanoma that became widely metastatic and progressive despite multiple systemic treatments. He became refractory to ipilimumab (Yervoy) and pembrolizumab (Keytruda). He presented with a very large, painful left posterior neck mass that was 18...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Cureus
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725734/ |